Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-26

Clinical Trial Update: Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for AMG 827 in adults with rheumatoid arthritis across phase 1 and phase 2, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMG 827

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-26